Development of a CRISPR-Cas9 System for Efficient Genome Editing of Candida lusitaniae

The ability to perform efficient genome editing is a key development for detailed mechanistic studies of a species. Candida lusitaniae is an important member of the Candida clade and is relevant both as an emerging human pathogen and as a model for understanding mechanisms of sexual reproduction. We highlight the development of a CRISPR-Cas9 system for efficient genome manipulation in C. lusitaniae and demonstrate the importance of species-specific promoters for expression of CRISPR components. We also demonstrate that the NHEJ pathway contributes to non-template-mediated repair of DNA DSBs and that removal of this pathway enhances efficiencies of gene targeting by CRISPR-Cas9. These results therefore establish important genetic tools for further exploration of C. lusitaniae biology. ABSTRACT Candida lusitaniae is a member of the Candida clade that includes a diverse group of fungal species relevant to both human health and biotechnology. This species exhibits a full sexual cycle to undergo interconversion between haploid and diploid forms. C. lusitaniae is also an emerging opportunistic pathogen that can cause serious bloodstream infections in the clinic and yet has often proven to be refractory to facile genetic manipulations. In this work, we develop a clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated gene 9 (Cas9) system to enable genome editing of C. lusitaniae. We demonstrate that expression of CRISPR-Cas9 components under species-specific promoters is necessary for efficient gene targeting and can be successfully applied to multiple genes in both haploid and diploid isolates. Gene deletion efficiencies with CRISPR-Cas9 were further enhanced in C. lusitaniae strains lacking the established nonhomologous end joining (NHEJ) factors Ku70 and DNA ligase 4. These results indicate that NHEJ plays an important role in directing the repair of DNA double-strand breaks (DSBs) in C. lusitaniae and that removal of this pathway increases integration of gene deletion templates by homologous recombination. The described approaches significantly enhance the ability to perform genetic studies in, and promote understanding of, this emerging human pathogen and model sexual species. IMPORTANCE The ability to perform efficient genome editing is a key development for detailed mechanistic studies of a species. Candida lusitaniae is an important member of the Candida clade and is relevant both as an emerging human pathogen and as a model for understanding mechanisms of sexual reproduction. We highlight the development of a CRISPR-Cas9 system for efficient genome manipulation in C. lusitaniae and demonstrate the importance of species-specific promoters for expression of CRISPR components. We also demonstrate that the NHEJ pathway contributes to non-template-mediated repair of DNA DSBs and that removal of this pathway enhances efficiencies of gene targeting by CRISPR-Cas9. These results therefore establish important genetic tools for further exploration of C. lusitaniae biology.

[1]  D. Hogan,et al.  Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species , 2017, mSphere.

[2]  H. Ng,et al.  Dramatic Improvement of CRISPR/Cas9 Editing in Candida albicans by Increased Single Guide RNA Expression , 2017, mSphere.

[3]  M. Ghannoum,et al.  The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation , 2017, Antimicrobial Agents and Chemotherapy.

[4]  Marek S. Skrzypek,et al.  The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data , 2016, Nucleic Acids Res..

[5]  O. Jousson,et al.  Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract , 2016, Front. Microbiol..

[6]  A. Mitchell,et al.  Candida albicans Gene Deletion with a Transient CRISPR-Cas9 System , 2016, mSphere.

[7]  Gareth Bloomfield,et al.  Atypical ploidy cycles, Spo11, and the evolution of meiosis. , 2016, Seminars in cell & developmental biology.

[8]  M. Sogin,et al.  Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease , 2016, PloS one.

[9]  D. Sanglard,et al.  Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy , 2015, Antimicrobial Agents and Chemotherapy.

[10]  Gerald R. Fink,et al.  A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families , 2015, Science Advances.

[11]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[12]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[13]  R. Bennett,et al.  The cryptic sexual strategies of human fungal pathogens , 2014, Nature Reviews Microbiology.

[14]  R. Bennett,et al.  Convergent Evolution of a Fused Sexual Cycle Promotes the Haploid Lifestyle , 2014, Nature.

[15]  Nicolas Papon,et al.  Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm , 2013, PLoS pathogens.

[16]  T. E. Wilson,et al.  Repair of double-strand breaks by end joining. , 2013, Cold Spring Harbor perspectives in biology.

[17]  A. Simkin,et al.  Efficient gene targeting in a Candida guilliermondii non-homologous end-joining pathway-deficient strain , 2013, Biotechnology Letters.

[18]  S. Giri,et al.  A review of Candida species causing blood stream infection. , 2012, Indian journal of medical microbiology.

[19]  Joseph Heitman,et al.  The Evolution of Sex: a Perspective from the Fungal Kingdom , 2010, Microbiology and Molecular Biology Reviews.

[20]  G. Butler.  Fungal Sex and Pathogenesis , 2010, Clinical Microbiology Reviews.

[21]  J. Heitman,et al.  Mechanistic Plasticity of Sexual Reproduction and Meiosis in the Candida Pathogenic Species Complex , 2009, Current Biology.

[22]  Manuel A. S. Santos,et al.  Evolution of pathogenicity and sexual reproduction in eight Candida genomes , 2009, Nature.

[23]  D. Kontoyiannis,et al.  Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. , 2008, Medical mycology.

[24]  S. Krappmann.  Gene targeting in filamentous fungi: the benefits of impaired repair , 2007 .

[25]  Hauke Harms,et al.  Debaryomyces hansenii — an extremophilic yeast with biotechnological potential , 2006, Yeast.

[26]  S. Osmani,et al.  A Versatile and Efficient Gene-Targeting System for Aspergillus nidulans , 2006, Genetics.

[27]  M. Chovanec,et al.  Non-homologous end-joining factors of Saccharomyces cerevisiae. , 2004, FEMS microbiology reviews.

[28]  R. Kolter,et al.  The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. , 2004, Gene.

[29]  L. Baddour,et al.  Candida lusitaniae infections in the era of fluconazole availability. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  I. Raad,et al.  Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  P. Spagnuolo,et al.  Emergence of a new opportunistic pathogen, Candida lusitaniae , 1989, Journal of clinical microbiology.

[32]  J. C. Christenson,et al.  Candida lusitaniae: an emerging human pathogen. , 1987, The Pediatric infectious disease journal.

[33]  C. Schild-Poulter,et al.  The Ku heterodimer: function in DNA repair and beyond. , 2015, Mutation research. Reviews in mutation research.

[34]  S. Keeney,et al.  Mechanism and regulation of meiotic recombination initiation. , 2014, Cold Spring Harbor perspectives in biology.